下丘脑电路对于针的抗帕金森效应的核心作用
Ju-Young Oh1,2, Hyowon Lee1,3, Sun-Young Jang1,2
1College of Korean Medicine, Kyung Hee University, Seoul, 02447, Republic of Korea.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|August 9, 2024
概括
针可以激活大脑中的黑色素缩激素 (MCH) 神经元,为其在帕金森病 (PD) 治疗中的有效性提供神经生物学解释. 这项研究确定了特定的MCH通路,这些通路对于PD中运动和记忆的改善至关重要.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 神经科学是一个神经科学.
- 传统中国医药 传统中国医药
背景情况:
- 针在中枢神经系统疾病,特别是帕金森病 (PD) 中的有效性背后的神经生物学机制,尽管在临床上广泛使用,但仍然在很大程度上是未知的.
- 现有研究强调需要科学解释,将针的治疗效果与特定的神经回路和细胞过程联系起来.
研究的目的:
- 阐明针在治疗帕金森病 (PD) 的疗效的神经生物学基础.
- 为了确定特定的神经通路和神经元群体被针激活,这有助于PD症状改善.
- 探索针对这些已识别的神经回路的潜力,用于新的PD治疗策略.
主要方法:
- 利用帕金森病 (PD) 的小鼠模型来研究针治疗效果.
- 采用神经传导研究来追踪外围针刺激对下丘脑黑色素缩激素 (MCH) 神经元的影响.
- 使用化学遗传学选择性地操纵不同的MCH神经元亚群及其投射到黑质体和海马体.
主要成果:
- 周围针刺激被证明可以通过神经传导在PD模型小鼠中激活下丘脑MCH神经元.
- 确定了两个不同的MCH神经通路:一个投射到黑质体 (运动控制),另一个投射到海马体 (记忆).
- 这些MCH投射的化学遗传向证明了它们在针诱导的运动恢复和记忆增强中的作用,以及缓解多巴胺基神经退行症和改善突触可塑性.
结论:
- 黑色素缩激素 (MCH) 神经元为针在帕金森病 (PD) 的治疗效果提供了基于电路的神经生物学解释.
- 针对特定的MCH神经通路提供了一个潜在的细胞策略,用于治疗PD的运动和非运动症状.
- 这项研究将传统的针实践与现代神经科学联系在一起,为基于证据的治疗开发铺平了道路.
相关概念视频
01:24Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
01:37Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
01:15Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
650
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
650